scholarly journals Еxtraintestinal manifestations of inflammatory bowel disease

Inflammatory bowel diseases, that include Crohn's disease and ulcerative colitis, are considered systemic processes since their symptoms and manifestations are not limited to the gastrointestinal tract. Extraintestinal manifestations are characteristic of inflammatory bowel disease and can be observed in almost every system of the patient’s body. Extraintestinal symptoms are present in approximately 42 % of patients with inflammatory bowel disease during the manifestation of the pathological process. They can also precede the onset of gastrointestinal symptoms. Nowadays, the pathogenesis of extraintestinal manifestations of inflammatory bowel disease is not completely obvious. It is currently believed that the mucous membrane of the patient's gastrointestinal tract can provoke an immune response in the extraintestinal areas due to the presence of common epitopes in individuals with a genetic predisposition. Extraintestinal symptoms are most often observed in the joints (peripheral and axial arthropathy), skin (nodular erythema, gangrenous pyoderma, aphthous stomatitis), visual organ (episcleritis, uveitis) and hepatobiliary system (primary sclerosing cholangitis). Other organs and systems of the body, such as the lungs, kidneys, pancreas and venous system, are also affected; however, their damages are much less common. Some extraintestinal manifestations, for instance arthritis of several joints, erythema nodosum, episcleritis, and aphthous ulcers of the oral cavity, are associated with inflammatory activity in the intestine. Other extraintestinal symptoms, such as uveitis and ankylosing spondylitis, are not associated with inflammatory bowel disease activity. Manifestations like primary sclerosing cholangitis and gangrenous pyoderma may or may not be associated with inflammatory bowel activity. Extraintestinal manifestations of inflammatory bowel disease exacerbate the negative impact of the pathological process on the patient's quality of life, and some of them, such as venous thromboembolism, can be life-threatening.

2012 ◽  
Vol 2012 ◽  
pp. 1-7 ◽  
Author(s):  
Victor Uko ◽  
Suraj Thangada ◽  
Kadakkal Radhakrishnan

Disorders of the hepatobiliary system are relatively common extraintestinal manifestations of inflammatory bowel disease (IBD). These disorders are sometimes due to a shared pathogenesis with IBD as seen in primary sclerosing cholangitis (PSC) and small-duct primary sclerosing cholangitis (small-duct PSC). There are also hepatobiliary manifestations such as cholelithiasis and portal vein thrombosis that occur due to the effects of chronic inflammation and the severity of bowel disease. Lastly, medications used in IBD such as sulfasalazine, thiopurines, and methotrexate can adversely affect the liver. It is important to be cognizant of these disorders as some do have serious long-term consequences. The management of these disorders often requires the expertise of multidisciplinary teams to achieve the best outcomes.


2020 ◽  
pp. 26-32
Author(s):  
Macarena Klein ◽  
Paulina Núñez ◽  
Constanza Bay ◽  
Carolina Pizarro ◽  
Rocío Sedano ◽  
...  

Abnormal liver tests are frequent in patients with inflammatory bowel disease. These may occur at the time of diagnosis or throughout the course of the disease. There are multiple aetiologies, such as concomitant diseases and extraintestinal manifestations of the same disease, primary sclerosing cholangitis being the most characteristic. Other aetiologies include adverse reactions to the drugs used in the treatment of these patients. This review will evaluate the different causes of liver test abnormalities.


2020 ◽  
Vol 158 (6) ◽  
pp. S-732-S-733
Author(s):  
Camilla A. Martins ◽  
Ana Elisa R. Caon ◽  
Marilia G. Cruz ◽  
Luísa L. Barros ◽  
Alexandre Carlos ◽  
...  

2018 ◽  
Vol 2 (8) ◽  
pp. 960-971 ◽  
Author(s):  
Brian K. Chung ◽  
Eva Kristine Klemsdal Henriksen ◽  
Kristin Kaasen Jørgensen ◽  
Tom H. Karlsen ◽  
Gideon M. Hirschfield ◽  
...  

2009 ◽  
Vol 136 (5) ◽  
pp. A-203
Author(s):  
Ashwin N. Ananthakrishnan ◽  
Dawn B. Beaulieu ◽  
Amar S. Naik ◽  
Yelena Zadvornova ◽  
Susan Skaros ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document